NAFLD and Cardiovascular Diseases: Epidemiological, Mechanistic and Therapeutic Considerations
David Niederseer(University of Zurich), Christian Datz(Paracelsus Medical University), Elmar Aigner, Bernhard Wernly(Paracelsus Medical University), Felix Stickel(University of Bern)
Cited by 76
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
|Journal of Hepatology|2020|361
Virtual and augmented reality in critical care medicine: the patient’s, clinician’s, and researcher’s perspective
|Critical Care|2022|229
The impact of frailty on survival in elderly intensive care patients with COVID-19: the COVIP study
|Critical Care|2021|188
Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue
|International Journal of Obesity|2012|168